| Literature DB >> 29140707 |
Javier Saenz1, Consuelo Santa-María2, María Edith Reyes-Quiroz1, Isabel Geniz3, Juan Jiménez1, Francisco Sobrino1, Gonzalo Alba1.
Abstract
The present work investigates the modulation of grapefruit flavonoid naringenin over liver X receptor alpha (LXRα) and its target genes in THP-1 macrophages, focusing on AMP-activated protein kinase (AMPK) implication. Naringenin induced LXRα at mRNA and protein levels besides influencing the expression of LXRα target genes ABCA1, ABCG1 (ATP-binding cassette A1 and G1), and SREBP1c (sterol response element binding protein 1c) in THP-1 macrophages. The increased LXRα mRNA and protein expression was reverted when AMPK was inhibited by its chemical inhibitor, compound C or by transfection with AMPK α1 and α2 siRNA. Naringenin treatments were also able to promote reverse cholesterol transport in THP-1 cells, which is in line with the increase in the ABCA1 and ABCG1 expression found. Treatments with this flavonoid also inhibited cell migration in THP-1 cells. In conclusion, LXRα and its target genes are up-regulated by naringenin in an AMPK dependent manner in human macrophages. The enhancement in the expression of genes involved in cholesterol efflux may reveal a new mechanism by which this polyphenol can prevent atherosclerosis and foam cell progression.Entities:
Keywords: AMPK; LXRα; THP-1; atherosclerosis; inflammation; naringenin
Mesh:
Substances:
Year: 2018 PMID: 29140707 DOI: 10.1021/acs.molpharmaceut.7b00797
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939